Growth hormone and body composition in children younger than 2 years with Prader-Willi syndrome.

@article{Eiholzer2004GrowthHA,
  title={Growth hormone and body composition in children younger than 2 years with Prader-Willi syndrome.},
  author={Urs Eiholzer and Dagmar L'allemand and Michael Schlumpf and Valentin Rousson and Theo Gasser and Christoph Fusch},
  journal={The Journal of pediatrics},
  year={2004},
  volume={144 6},
  pages={753-8}
}
OBJECTIVES To assess body composition of infants with Prader-Willi syndrome (PWS) by using deuterium dilution and investigating the efficacy of early institution of growth hormone (GH) therapy in increasing lean mass (LM) and preventing massive obesity. STUDY DESIGN One group of 11 children with PWS <2 years before and during 30-month GH therapy (GH group) was compared with 6 infants administered only coenzyme Q(10) for 1 year (Q10 group). LM adjusted for height (LM(Ht)) and relative fat mass… CONTINUE READING